LRTM2 anticorps (AA 36-310) (HRP)
Aperçu rapide pour LRTM2 anticorps (AA 36-310) (HRP) (ABIN7158065)
Antigène
Voir toutes LRTM2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 36-310
-
Réactivité croisée
- Humain
-
Purification
- >95%, Protein G purified
-
Immunogène
- Recombinant Human Leucine-rich repeat and transmembrane domain-containing protein 2 protein (36-310AA)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- LRTM2 (Leucine-Rich Repeats and Transmembrane Domains 2 (LRTM2))
-
Autre désignation
- LRTM2
-
Sujet
-
Background: cytoplasm, protein kinase inhibitor activity, cytokine-mediated signaling pathway, negative regulation of JAK-STAT cascade, negative regulation of protein kinase activity.
Aliases: Leucine-rich repeat and transmembrane domain-containing protein 2 antibody, Leucine-rich repeats and transmembrane domains 2 antibody, Lrtm2 antibody, LRTM2_HUMAN antibody
-
UniProt
- Q8N967
Antigène
-